78 results on '"Loussouarn, Delphine"'
Search Results
2. Deep Learning Methodologies Applied to Digital Pathology in Prostate Cancer: A Systematic Review
3. Spatial Distribution of Immune Cells in Primary and Recurrent Glioblastoma: A Small Case Study
4. Figure S6 from Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity
5. Figure S3 from Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity
6. Figure S1 from Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity
7. Figure S7 from Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity
8. Figure S4 from Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity
9. Figure S1 from Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity
10. Figure S2 from Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity
11. Figure S2 from Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity
12. Figure S6 from Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity
13. Figure S5 from Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity
14. Supplementary Tables from Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity
15. Figure S5 from Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity
16. Supplementary Tables from Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity
17. Figure S7 from Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity
18. Figure S3 from Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity
19. Figure S4 from Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity
20. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group
21. Prognostic value of hPG80 (circulating progastrin) in IDH-wild type glioblastoma treated with radio-chemotherapy.
22. A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patients with early HER2-positive breast cancer and predictive biomarkers (RADHER trial)
23. Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort
24. Cardiomyopathies inflammatoires : diagnostic, corrélations avec l’imagerie, intérêt de la biopsie myocardique et place de la biologie moléculaire
25. Meningiomas and cyproterone acetate: a retrospective, monocentric cohort of 388 patients treated by surgery or radiotherapy for intracranial meningioma
26. One‐year conditional survival of dogs and cats with invasive mammary carcinomas: A concept inspired from human breast cancer
27. STING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment
28. Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer
29. CD8+ T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome
30. Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study
31. Androgen receptor and FOXA1 coexpression define a “luminal-AR” subtype of feline mammary carcinomas, spontaneous models of breast cancer
32. Proposal for a Histological Staging System of Mammary Carcinomas in Dogs and Cats. Part 1: Canine Mammary Carcinomas
33. Proposal for a Histological Staging System of Mammary Carcinomas in Dogs and Cats. Part 2: Feline Mammary Carcinomas
34. PDTM-24. PINEOBLASTOMA SEGREGATES INTO MOLECULAR SUBTYPES WITH DISTINCT CLINICOPATHOLOGIC FEATURES: REPORT FROM THE RARE BRAIN TUMOUR CONSORTIUM
35. Combined chemotherapy and allogeneic human Vγ9Vδ2 T lymphocyte-immunotherapies efficiently control the development of human epithelial ovarian cancer cells in vivo
36. Feline Invasive Mammary Carcinomas: Prognostic Value of Histological Grading
37. Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
38. Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study
39. EMBR-17. PINEOBLASTOMA SEGREGATES INTO MOLECULAR SUBTYPES WITH DISTINCT CLINICOPATHOLOGIC FEATURES: REPORT FROM THE RARE BRAIN TUMOR CONSORTIUM
40. Un rare cas de lymphome T cytotoxique cérébral primitif
41. Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors
42. Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance
43. Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity
44. Pharmacological targeting of apelin impairs glioblastoma growth
45. Abstract 1137: ADAM8 drives aggressive phenotype of triple-negative inflammatory breast cancer & constitutes a novel therapeutic target
46. Proposed revised criteria for the diagnosis of CLIPPERS (P1.329)
47. Tumeurs fibreuses solitaires et hémangiopéricytomes des méninges : immunophénotype et évaluation du grade histopronostique dans 17 cas
48. Predictive value of intratumoral signaling and immune infiltrate for response to preoperative (PO) trastuzumab (T) vs trastuzumab + everolimus (T+E) in patients (pts) with primary breast cancer (PBC): UNICANCER RADHER trial results.
49. Mitotic index, microvascular proliferation, and necrosis define 3 pathological subgroups of prognostic relevance among 1p/19q co-deleted anaplastic oligodendrogliomas
50. Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.